Enhanced desorption of fluoxetine from polyethylene terephthalate microplastics in gastric fluid and sea water

Abstract

There are concerns that microplastics act as a vector of pharmaceuticals in the aquatic environment. Most studies have focussed on pharmaceutical adsorption and have not investigated desorption in the various matrices that microplastics enter. Therefore we studied the desorption of the antidepressant drug fluoxetine from polyethylene terephthalate (PET) microplastics in river water, sea water, and simulated gastric and intestinal fluids. We found that most desorption occurred rapidly, within a few hours of exposure. Fluoxetine desorption fitted well to the Freundlich isotherm with r2 values ranging from 0.97 to 0.99. Desorption decreased in the following order: gastric fluid at 20 °C and 37 °C; sea water at 20 °C; intestinal fluid at 20 °C and 37 °C; then river water at 20 °C. The little difference in desorption in gastrointestinal fluids at 20 °C and 37 °C suggests a similar exposure risk to cold- and warm-blooded organisms following PET microplastic ingestion. Total desorption following sequential incubation 2 h in gastric fluid then 4 h in intestinal fluid to mimic gastrointestinal digestion was 37% at 20 °C and 41% at 37 °C. Interestingly, higher desorption of 18–23% occurred in sea water compared to river water, of 4–11%. Under a worst-case scenario, more than 44 mg kg−1 body weight d−1 or more than 52 mg kg−1 body weight d−1 of PET microplastics from river water or sea water, respectively, need to be consumed to exceed the mammalian acceptable daily intake for fluoxetine. Further studies are needed on microplastic ingestion and the bioavailability of adsorbed pharmaceuticals to a range of exposed aquatic organisms.